|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 500 WEST MAIN STREET |
Address2 |
|
City | LOUISVILLE |
State | KY |
Zip Code | 40202 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 18912-12
|
||||||||
|
6. House ID# 322890000
|
TYPE OF REPORT | 8. Year | 2021 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Alyssa Greenhut |
Date | 10/20/2021 6:25:00 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
CMS-9115-P Interoperability and Patient Access Final Rule
HHS ONC RIN-0955-AA01 - 21st Century Cures Interoperability and Information Blocking Final Rule
H.R. 3, Elijah E. Cummings Lower Drug Prices Now Act
S. 2543, Prescription Drug Pricing Reduction Act of 2019 (116th Congress)
S. 2164, Lower Cost, More Cures Act of 2021
COVID-19 Response, including COVID-19 bills legislation implementation
The Senate Amendment to H.R. 133, Consolidated Appropriations Act, 2021 (surprise billing legislation implementation)
H.R. 19, Lower Cost, More Cures Act of 2021
H.R. 5376, Build Back Better Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), White House Office, Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Food & Drug Administration (FDA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Magnuson |
|
|
|
Jeffrey |
Lungren |
|
|
|
Keith |
Zuegel |
|
|
|
Alexander |
Ware |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
COVID-19 Response, including COVID-19 bills legislation implementation
Medicare Advantage Policy and Reimbursement
2022 Medicare Advantage Advance Rate Notice
CMS - 4180-P, Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Medicaid and Dual Eligible Issues
Medicare Part D Issues
Medicaid and Dual Eligible Issues
Pharmacy Reimbursement Issues
Medicare Home Health Issues
Rebate Rule
S. 150/H.R. 2166, Ensuring Parity in MA for Audio-Only Telehealth Act of 2021
H.R. 4074, A bill to expand the availability of supplemental benefits to certain Medicare Advantage enrollees
Medicare Hospice Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), White House Office, Office of Management & Budget (OMB)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Magnuson |
|
|
|
Jeffrey |
Lungren |
|
|
|
Alexander |
Ware |
|
|
|
Keith |
Zuegel |
|
|
|
Chris |
Downing |
|
Director, Office of Public Affairs, Admin. for Children and Families, HHS; Regional Director, Office of the Secretary, HHS |
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DEF
16. Specific lobbying issues
COVID-19 Response, including COVID-19 bills legislation implementation
Tricare Issues
NDAA Implementation Issues
Military Families, Veterans
Improving Veterans Healthcare
Telehealth
Value-Based Care
National Defense Authorization Act for Fiscal Year 2022
H.R.475 - Health Care Fairness for Military Families Act of 2021
S. 1972: Health Care Fairness for Military Families Act of 2021
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Defense - Dept of (DOD)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Magnuson |
|
|
|
Jeffrey |
Lungren |
|
|
|
Keith |
Zuegel |
|
|
|
Alexander |
Ware |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
COVID-19 Response
Tax Reform Implementation Issues
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Treasury - Dept of, White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Rachel |
Magnuson |
|
|
|
Jeffrey |
Lungren |
|
|
|
Keith |
Zuegel |
|
|
|
Alexander |
Ware |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |